Standard & Poor’s Confirms Rating for Gerresheimer
Standard & Poor’s has today confirmed the current rating of BB+ for the
Gerresheimer Group and continues to categorize the outlook as stable. The
focus of the MDAX company on the pharma & life science industry is therefore
assessed as positive and sustainable by the rating agency.
Gerresheimer employs around 10,000 people in 42 locations in
glass and plastic through to complex drug-delivery systems for the pharma &
life science industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.
Contact Press Burkhard Lingenberg Director Corporate Communication & Marketing Phone +49-211-6181-250 Fax +49-211-6181-241 e-mail firstname.lastname@example.org Contact Investor Relations Anke Linnartz Director Corporate Investor Relations Phone +49-211-6181-314 Fax +49-211-6181-121 e-mail email@example.com
SOURCE Gerresheimer AG